Can I read ASCENT-03 Trial Results for mTNBC Treatment on EtoBox?
ASCENT-03 Trial Results for mTNBC Treatment by Harish Gorrepati is a document available to read on EtoBox.
What is ASCENT-03 Trial Results for mTNBC Treatment about?
The ESMO Congress 2025 presented results from multiple studies, including the ASCENT-03 trial, which showed that sacituzumab govitecan (SG) significantly improved progression-free survival in patients with previously untreated advanced triple-negative breast cancer unable to receive PD-(L)1 inhibitors. Additionally, the KEYNOTE-689 trial highlighted that neoadjuvant-adjuvant pembrolizumab combined with standard-of-care maintained stable quality of life in patients with locally advanced head and neck squamou
- Author
- Harish Gorrepati
- Language
- EN